Consolidated Statement Of Cash Flows

ONO PHARMACEUTICAL CO., LTD. - Filing #7302958

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
41,641,000,000 JPY
41,641,000,000 JPY
41,647,000,000 JPY
6,000,000 JPY
74,491,000,000 JPY
74,491,000,000 JPY
29,000,000 JPY
74,520,000,000 JPY
Depreciation and amortization
8,996,000,000 JPY
9,086,000,000 JPY
Impairment losses (reversal of impairment losses)
3,510,000,000 JPY
5,440,000,000 JPY
Decrease (increase) in inventories
207,000,000 JPY
-3,476,000,000 JPY
Increase (decrease) in retirement benefit liability
-195,000,000 JPY
-2,000,000 JPY
Other
-3,988,000,000 JPY
-595,000,000 JPY
Subtotal
55,630,000,000 JPY
70,206,000,000 JPY
Interest received
279,000,000 JPY
66,000,000 JPY
Dividends received
1,264,000,000 JPY
1,271,000,000 JPY
Interest paid
-293,000,000 JPY
-46,000,000 JPY
Income taxes paid
-22,157,000,000 JPY
-34,776,000,000 JPY
Net cash provided by (used in) operating activities
34,723,000,000 JPY
36,721,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,806,000,000 JPY
-2,510,000,000 JPY
Proceeds from sale of property, plant and equipment
6,000,000 JPY
842,000,000 JPY
Purchase of intangible assets
-1,975,000,000 JPY
-6,381,000,000 JPY
Payments for acquisition of subsidiaries
-364,816,000,000 JPY
JPY
Other
-532,000,000 JPY
-2,140,000,000 JPY
Net cash provided by (used in) investing activities
-160,930,000,000 JPY
20,713,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
150,000,000,000 JPY
JPY
Purchase of treasury shares
-1,000,000 JPY
-27,187,000,000 JPY
Dividends paid
-18,754,000,000 JPY
-18,049,000,000 JPY
Dividends paid to non-controlling interests
-11,000,000 JPY
-9,000,000 JPY
Net cash provided by (used in) financing activities
129,687,000,000 JPY
-46,647,000,000 JPY
Net increase (decrease) in cash and cash equivalents
3,480,000,000 JPY
10,787,000,000 JPY
Cash and cash equivalents
167,090,000,000 JPY
166,141,000,000 JPY
107,704,000,000 JPY
96,135,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-2,530,000,000 JPY
782,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.